| http://www.w3.org/ns/prov#value | - Another problem is that not every kind of animal model is suitable for testing the safety of an AD vaccine, since even AN1792 did not induce inflammation in various types of animals, including APP transgenic mouse models of AD. In addition, I think it is unlikely that the FDA or other regulatory agencies will allow another clinical trial based on full-length A??42 peptide immunization.
|
